ALLIANCE PHARMACEUTICAL CORP
10-K, EX-23.1, 2000-09-01
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: ALLIANCE PHARMACEUTICAL CORP, 10-K, EX-21, 2000-09-01
Next: ALLIANCE PHARMACEUTICAL CORP, 10-K, EX-27, 2000-09-01



<PAGE>


                                                                    Exhibit 23.1











               CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS



We consent to the incorporation by reference in the Registration Statements
(Forms S-3 and S-8) of Alliance Pharmaceutical Corp. of our report dated
August 1, 2000, with respect to the consolidated financial statements of
Alliance Pharmaceutical Corp. included in the Annual Report (Form 10-K) for
the year ended June 30, 2000.

                                                 ERNST & YOUNG LLP


San Diego, California
August 31, 2000


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission